about
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairsIdentification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cellsBone morphogenetic protein-9 is a circulating vascular quiescence factorStructural basis for specificity of TGFβ family receptor small molecule inhibitorsA role for the TGFbeta-Par6 polarity pathway in breast cancer progressionFunctional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.Does sperm origin affect embryo morphokinetic parameters?Emerging role of bone morphogenetic proteins in angiogenesis.MBNL proteins repress ES-cell-specific alternative splicing and reprogramming.The TGFβ superfamily in stem cell biology and early mammalian embryonic development.Phases of reprogramming.Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells.BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8(+) T cells involved in multiple sclerosis.A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network.Molecular Mechanisms of Stem Cell Pluripotency and Cell Fate Specification.Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.[Mesenchymal-to-epithelial transition: a necessary initial step towards reprogrammation of fibroblasts].How Tets and cytoskeleton dynamics MET in reprogramming.Improved Analyses of CD8+ T Cell Specificities Using Multimers of Peptide MHC Complexes Coupled to DNA BarcodesLa reprogrammation, un jeu de hasard ?Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: Potential roles for JNK and ERKSTING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
P50
Q24297719-3766A01A-41BB-43C5-97D6-6276891B3A05Q24309588-23913FC5-22A9-430B-B5F0-7F9179252F24Q24657942-8C8F6CBD-45A4-4F89-AABC-3CFCA2F606B0Q27674793-3FEF851A-82DB-47A5-A7E4-98E8E2C5A57DQ30489618-13121D26-87A9-486A-B25C-C65940788FBAQ34125369-D080ED9F-1901-4004-890A-F973E5F42868Q36127764-EF6BF1E7-1683-4CB3-AD98-415DF3E251E0Q37510292-1E0D6CAD-C393-4E7F-85FD-DB77F1EB71E2Q37601795-E16928A4-0D78-4730-B491-8B9E376FC361Q38042503-0E6E4600-45AA-43D0-BDF7-2A8041ADFCE6Q38204845-A3251232-FD2C-43FF-B332-133709BD9DCBQ41863264-A509ECB8-1C79-4EFA-BC67-D7C79D2FFE53Q42808856-179B254C-C756-40AC-BC32-BEF693C29EFAQ47751937-2A064368-3877-47B8-906B-5246C2E10858Q50771817-2A027B27-B495-4893-A400-40E24066BE1DQ51096155-611FA59A-FA8A-407B-87BD-C1F64439F052Q51724062-841811E4-0F21-4619-B4F4-E3D008B1AD15Q51892614-AC001E90-6CF6-42D6-8BDA-F4186025845EQ54362388-42B5B4D6-C8D1-4614-8210-D2D38C2F6835Q58336640-DD2E0826-0BA8-4A6F-B62C-6F7447B871D8Q58336642-49263B54-D2B0-4F8E-BA2D-F97CA10107BAQ58336647-FF46D30F-5499-4E2F-BEE1-51F9E42C6081Q92642973-2BE87C3F-BF2C-44FD-A62E-A6D4E4BFB990
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Laurent David
@ast
Laurent David
@en
Laurent David
@es
Laurent David
@nl
Laurent David
@sl
type
label
Laurent David
@ast
Laurent David
@en
Laurent David
@es
Laurent David
@nl
Laurent David
@sl
prefLabel
Laurent David
@ast
Laurent David
@en
Laurent David
@es
Laurent David
@nl
Laurent David
@sl
P106
P21
P214
4146573826538101488
P31
P496
0000-0003-3594-0353
P735
P7859
viaf-4146573826538101488